Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 3.23 USD 4.19% Market Closed
Market Cap: 33.1m USD

Net Margin
Burning Rock Biotech Ltd

-67.2%
Current
-135%
Average
-7.9%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-67.2%
=
Net Income
-346.6m
/
Revenue
515.8m

Net Margin Across Competitors

Burning Rock Biotech Ltd
Glance View

Market Cap
33.1m USD
Industry
Biotechnology

Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2020-06-12. The firm operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The firm mainly conducts its businesses in the China market.

BNR Intrinsic Value
15.16 USD
Undervaluation 79%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-67.2%
=
Net Income
-346.6m
/
Revenue
515.8m
What is the Net Margin of Burning Rock Biotech Ltd?

Based on Burning Rock Biotech Ltd's most recent financial statements, the company has Net Margin of -67.2%.

Back to Top